Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Product
Deals
Articles
BioCentury
|
Mar 4, 2019
Distillery Therapeutics
Inhibiting soluble epoxide hydrolase for renal damage
...Phase I testing for diabetes and chronic obstructive pulmonary disease (COPD). TMS Co. Ltd. has
TMS-00X
...
Read More
BioCentury
|
Apr 25, 2017
Distillery Therapeutics
Dental
...inhibitor, in Phase I testing for chronic obstructive pulmonary disease (COPD). TMS Co. Ltd. has
TMS-00X
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page